Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [14C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers
Crossref DOI link: https://doi.org/10.1007/s00280-017-3383-9
Published Online: 2017-07-11
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gerisch, Michael
Schwarz, Thomas
Lang, Dieter
Rohde, Gabriele
Reif, Stefanie
Genvresse, Isabelle
Reschke, Susanne
van der Mey, Dorina
Granvil, Camille
Funding for this research was provided by:
Bayer
License valid from 2017-07-11